Published in Inflamm Bowel Dis on May 01, 2001
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol (2009) 2.72
Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res (2014) 1.07
Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study. BMC Gastroenterol (2009) 0.82
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. World J Gastroenterol (2011) 0.77
Medical management of Crohn's disease. Clin Colon Rectal Surg (2007) 0.76
Perioperative adjuvant therapy with infliximab in complicated anal Crohn's disease. Int J Colorectal Dis (2008) 0.76